Peer-reviewed articleOpen access

Intranasal 5-MeO-DMT Concomitant with SSRI for Treatment-Resistant Depression: A Proof-of-Concept Trial.

Seynaeve M iD, Dunbar F, Hindocha C, Ermakova AO, Pierce M, Conley RR, Roberts C

CNS drugsMar 24, 2026License: open accessUnited Kingdom, Canada0 citationsDOI: 10.1007/s40263-025-01250-z

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

DMT5-MeO-DMTDepression

View paper Full text (PDF)

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.

Related research

ArticleDMT

Beyond the toad's kiss: Mapping acute 5-MeO-DMT effects on brain connectivity across sex and dose using awake rat neuroimaging.

Cavallaro N, Rai P, Akins D +6

Europe PMC2026

ArticleKetamine

Candidate Biomarkers of Bipolar Disorder Progression: Implications for Ketamine and Psychedelic Interventions.

Wilkowska A, Nizgorska-Ohler J, Cubała WJ

Europe PMC2026

ArticlePsilocybin

The changing outlook of psychedelic drugs: The importance of risk assessment and occupational exposure limits.

Videira NB, Nair V, Paquet V +1

Europe PMC2024